|
Originally published In Press as doi:10.1194/jlr.D700010-JLR200 on September 13, 2007
Journal of Lipid Research, Vol. 48, 2769-2778, December 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
A rapid fluorescence assay for sphingosine-1-phosphate lyase enzyme activity
Padmavathi Bandhuvula1,
Henrik Fyrst1 and
Julie D. Saba2
Children's Hospital, Oakland Research Institute, Oakland, CA 94609
Published, JLR Papers in Press, September 13, 2007.
1 P. Bandhuvula and H. Fyrst contributed equally to this work.
2 To whom correspondence should be addressed. e-mail: jsaba{at}chori.org
Sphingosine-1-phosphate (S1P) lyase (SPL) catalyzes the conversion of S1P to ethanolamine phosphate and hexadecenal. This enzyme plays diverse roles in physiology and disease and, thus, may be useful as a disease marker and/or drug target. Unfortunately, the radioisotope-based assay currently used to quantify SPL activity is suboptimal. We have devised an assay using a commercially available (7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro (NBD)-labeled fluorescent substrate. Alternatively, we provide a method for synthesis of the substrate from NBD-sphingosine. Enzyme activity is determined by following the formation of NBD-aldehyde product, which is isolated from unreacted substrate by lipid extraction and quantified after separation by HPLC using a C18 column. A fluorescent NBD-C18-sphingosine internal standard is used to control for extraction efficiency. The reaction is linear over 20 min and total protein concentrations of 20–200 mg/l. The sensitivity of the fluorescence assay is comparable to or better than that of the radioactive assay, and SPL levels as low as 8 pmol/mg/min were readily detected. Semicarbazide, a nonspecific SPL inhibitor, reduced SPL activity in vitro by 70% using both standard and fluorescence methods. Product inhibition was not observed using ethanolamine phosphate and a commercially available source of hexadecenal. This method is suitable for quantifying SPL activity in a variety of cell and tissue sources.
Supplementary key words high-performance liquid chromatography (7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro-sphingosine sphingosine-1-phosphate dihydrosphingosine-1-phosphate Abbreviations: CLAP, chymostatin, leupeptin, antipain, and pepstatin A; DHS1P, dihydrosphingosine-1-phosphate; 2,4-DNPH, 2,4-dinitrophenylhydrazine; GFP, green fluorescent protein; LCBP, long-chain base phosphate; NBD, (7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro; S1P, sphingosine-1-phosphate; Sphk1, sphingosine kinase 1; SPL, sphingosine-1-phosphate lyase; TBAP, tetrabutylammonium-dihydrogen phosphate

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. J. Diab, J. J. Adamowicz, K. Kamocki, N. I. Rush, J. Garrison, Y. Gu, K. S. Schweitzer, A. Skobeleva, G. Rajashekhar, W. C. Hubbard, et al.
Stimulation of Sphingosine 1-Phosphate Signaling as an Alveolar Cell Survival Strategy in Emphysema
Am. J. Respir. Crit. Care Med.,
February 15, 2010;
181(4):
344 - 352.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|